| For: | Li Y, Wu YT, Wu H. Management of hepatic encephalopathy following transjugular intrahepatic portosystemic shunts: Current strategies and future directions. World J Gastroenterol 2025; 31(15): 103512 [PMID: 40309228 DOI: 10.3748/wjg.v31.i15.103512] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v31/i15/103512.htm |
| Number | Citing Articles |
| 1 |
Mengdi Lu, Jing Chen, Hong Zhang, Jia Xu, Xiaojiao Li, Yue Hu, Jingrui Liu, Changlin Ai, Chunhua Shi, Guozhu Geng, Zhenkun Ma, Junqi Niu, Yanhua Ding. A randomized, double-blind, placebo-controlled study to evaluate the safety, pharmacokinetics and ammonia-lowering effect of Rifaquizinone, an intestinally restricted investigational drug. Expert Opinion on Investigational Drugs 2026; 35(2): 169 doi: 10.1080/13543784.2026.2619604
|
| 2 |
Ziji Fang, Zhenwei Liu, ZaiChun Pu, Qi Xia, Qin Zhang, Li Wang, Ping Jia, Xiaobin Tang. Risk prediction models for hepatic encephalopathy following TIPS: a systematic review and meta-analysis. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1707035
|
| 3 |
Yue Xu, Qin Yin, Jiangqiang Xiao, Qing Zhao, Xiaotian Chen, Ming Zhang, Bo Gao. Impact of quantitative dietary guidance on postoperative outcomes in patients undergoing transjugular intrahepatic portosystemic shunt surgery: a retrospective cohort study. Frontiers in Nutrition 2026; 13 doi: 10.3389/fnut.2026.1671392
|
